Multimodal Deep Learning for Prognosis Prediction in Renal Cancer

Area of Science:

• Oncology
• Medical Imaging
• Genomics
• Artificial Intelligence

Background:

• Clear-cell renal cell carcinoma (ccRCC) presents a significant mortality challenge.
• Current prognostic tools for ccRCC, such as TNM staging and histopathological grading, are limited.
• The integration of complex, multimodal data from urology, radiology, oncology, and pathology is crucial for advancing ccRCC patient care.

Purpose of the Study:

• To develop and evaluate a multimodal deep learning model (MMDLM) for predicting prognosis in clear-cell renal cell carcinoma (ccRCC).
• To assess the efficacy of integrating histopathological images, radiological scans, and genomic data for ccRCC prognosis prediction.

Main Methods:

• A multimodal deep learning model (MMDLM) was trained on data from two ccRCC patient cohorts (The Cancer Genome Atlas and Mainz).
• The MMDLM utilized multiscale histopathological images, CT/MRI scans, and whole exome sequencing genomic data.
• Model performance was evaluated using Harrell's concordance index (C-index) and 5-year survival status prediction accuracy.

Main Results:

• The MMDLM demonstrated strong prognostic performance with a mean C-index of 0.7791 and 83.43% accuracy for 5-year survival prediction.
• Combining data from multiple sources significantly improved prediction accuracy compared to using single data types.
• The MMDLM's predictions were found to be an independent prognostic factor, outperforming existing clinical parameters.

Conclusions:

• Multimodal deep learning offers a powerful approach for enhancing prognosis prediction in ccRCC.
• The developed MMDLM has the potential to significantly improve the clinical management of ccRCC patients.
• AI-driven analysis of integrated medical data can provide valuable insights into ccRCC patient survival outcomes.